⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of ROSEAId, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
ROSEAId, Inc.
↗Houston, Texas, United States
ROSEAId is a health sciences AI company that provides a cloud-based, AI-centric telepathology platform. The company focuses on empowering pathologists, researchers, and healthcare professionals by leveraging machine learning and advanced data analytics to improve the accuracy and speed of cancer detection and diagnostic workflows.
Established in 2020 through a collaboration with the University of Texas Health, the company develops integrated systems that combine digital pathology hardware with sophisticated AI algorithms. Their technology is designed to support clinical operations, research, and academia, with a particular focus on enabling remote analysis and collaboration to improve patient outcomes, especially in underserved communities.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Digital Pathology / AI Diagnostics
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Crewstone International
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Diagnostic Platform)
Modalities:AI-driven Diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Mikroscan Technologies (AI-powered microscopy system development), University of Texas Health (Research collaboration)
COMPETITION
Position:Emerging
Competitors:Ataraxis, Baracoda, EcgPlus, Techcyte
LEADERSHIP
Key Executives:
Joseph Rossi - CEO
Russell Raff - CPO, Co-Founder
Stephen Northrop - Founder, Managing Director
Scientific Founders:Russell Raff, Stephen Northrop
Board Members:Barak Tsivkin
LINKS
Website:roseaid.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ROSEAId, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.